Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Apr;15(4):898-905.
doi: 10.1128/JVI.15.4.898-905.1975.

Hexon peptides of type 2, 3, and 5 adenoviruses and their relationship to hexon structure

Hexon peptides of type 2, 3, and 5 adenoviruses and their relationship to hexon structure

M F Stinski et al. J Virol. 1975 Apr.

Abstract

Peptides of hexons from type 2 and 5 (subgroup III) and type 3 (subgroup I) adenoviruses were produced by treatment with cyanogen bromide and were separated by isoelectric focusing in polyacrylamide gels containing 8 M urea. Peptides with identical isoelectric points, but from different hexon types, were considered to have structural similarities. According to this criterion for chemical relatedness, about two-thirds of the type 2 and 5 hexon peptides may be considered similar. In contrast, the majority of the type 3 hexon peptides differed chemically from peptides of type 2 and 5 hexons. Virions and free hexons were iodinated with 125-I in the presence of lactoperoxidase and H-2-O-2. When 125-I-labeled virions were disrupted and the hexon was purified, the highly labeled cyanogen bromide peptides were labeled. When purified hexons from the excess cellular pool were iodinated, peptides common to types 2, 3, and 5 (peptides 12 and 14) were most extensively labeled. Thus, hexons assembled in virions and those free in solution were iodinated differently. The data suggest that immunologically the hexons in viral capsids react differently from unassembled hexons because the polypeptide chains assume slightly different folding configurations in the two hexon forms and therefore expose different regions of the protein to antibodies.

PubMed Disclaimer

References

    1. J Virol. 1970 May;5(5):586-97 - PubMed
    1. Arch Gesamte Virusforsch. 1972;36(1):80-92 - PubMed
    1. J Mol Biol. 1973 Feb 5;73(4):533-8 - PubMed
    1. J Gen Virol. 1970 Nov;9(2):163-7 - PubMed
    1. J Mol Biol. 1965 Aug;13(1):13-20 - PubMed

Publication types

LinkOut - more resources